Related Experiment Video
Updated: Nov 21, 2025
07:34
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
2.9K
IL-33 Changes Our "Gut Feelings" about Serotonin.
1Department of Integrative Biology & Physiology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Immunity
|January 13, 2021
Summary
Interleukin-33 (IL-33) signals immune cells to increase intestinal serotonin production, indirectly enhancing gut motility. This study clarifies a novel mechanism linking immune responses to gastrointestinal function.
Area of Science:
- Immunology
- Neurogastroenterology
- Gastrointestinal Physiology
Background:
- Direct interactions between immune cells and enteric neurons are established.
- The indirect modulation of enteric function via immune-mediated neurotransmitter regulation remains unclear.
Purpose of the Study:
- To investigate how immune signals indirectly influence enteric nervous system function.
- To elucidate the role of Interleukin-33 (IL-33) in regulating gut neurotransmitters and motility.
Main Methods:
- Utilized mouse models and in vitro cell cultures.
- Measured serotonin levels in response to IL-33 stimulation.
- Assessed the impact of IL-33 on gut motility.
Main Results:
- Chen et al. demonstrated that IL-33 induces the production of serotonin in the intestine.
- Increased serotonin levels were directly correlated with enhanced gut motility.
- This provides evidence for indirect immune modulation of enteric neurons.
Conclusions:
- IL-33 serves as a key immune mediator that enhances gut motility by upregulating intestinal serotonin.
- This finding reveals a novel pathway connecting immune system activation to gastrointestinal neuromuscular function.
Related Concept Videos
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
635
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
635
01:17Irritable Bowel Syndrome I: Introduction
674
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
674
01:24T Cell Types and Functions
1.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.8K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
433
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
433
01:23Anatomy of the Intestines
85.6K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
85.6K
01:23Renewal of Intestinal Stem Cells
2.9K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.9K